A study for a 43 year old man who takes Hydroxyzine - from FDA reports


Summary

1,759 males aged 43 (±5) who take the same drug are studied. This is a personalized study for a 43 year old male patient who has Psoriasis. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Sep, 20, 2017

1,759 males aged 43 (±5) who take Hydroxyzine are studied.


Number of reports submitted per year:

Hydroxyzine for a 43-year old man.

Information of the patient in this study:

  • Age: 43
  • Gender: male
  • Conditions: Psoriasis
  • Drugs taken:
    • Hydroxyzine (hydroxyzine hydrochloride)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • High Cholesterol: 23 (1.31% of males aged 43 (±5) who take the drug)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common side effects over time

< 1 month:
  • erythema multiforme
  • fever
  • eosinophil count increased
  • toxic skin eruption
  • rashes
  • drowsiness
  • dizziness
  • high blood pressure
  • cytolytic hepatitis
  • renal failure acute
1 - 6 months:
  • hepatic function abnormal
  • high blood cholesterol
  • blood lactic acid increased
  • white blood cell count abnormal
  • itching
  • platelet count abnormal
  • diabetic ketoacidosis
  • haematocrit
  • blood alkaline phosphatase increased
  • ileus paralytic
6 - 12 months:
  • headache
  • depression
  • quality of life decreased
  • raynaud's phenomenon
  • fall
  • hypoaesthesia
  • wrist fracture
  • appetite - decreased
  • weight decreased
  • pain in extremity
1 - 2 years:
  • rash erythematous
  • peritonitis bacterial
  • device related infection
  • vision blurred
  • diabetic retinopathy
  • drug-induced liver injury
  • hepatocellular damage
  • abdominal distension
  • malaise
  • hypoxic-ischaemic encephalopathy
2 - 5 years:
  • irritability
  • convulsion
  • loss of consciousness
  • mental disorder
  • depression
  • headache
5 - 10 years:
  • heart attack
  • rectal haemorrhage
  • gastrointestinal haemorrhage
10+ years:
n/a
not specified:
  • fever
  • rashes
  • nausea
  • fatigue
  • depression
  • chest pain
  • itching
  • breathing difficulty
  • weakness
  • weight decreased

Top conditions involved for these people *:

  • Depression (144 people, 8.19%)
  • Pain (121 people, 6.88%)
  • Bipolar Disorder (70 people, 3.98%)
  • High Blood Pressure (68 people, 3.87%)
  • Itching (64 people, 3.64%)

Top co-used drugs for these people *:

  • Seroquel (160 people, 9.10%)
  • Zyprexa (110 people, 6.25%)
  • Depakote (103 people, 5.86%)
  • Risperdal (98 people, 5.57%)
  • Ativan (92 people, 5.23%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

Can you answer these questions?

More questions for: Psoriasis, High cholesterol, Hydroxyzine

You may be interested in these reviews

More reviews for: Psoriasis, High cholesterol, Hydroxyzine